ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

13,364Medicare Part D Prescriptions Filled, Including Refills

Rank: 32 out of 393

$629K Total Retail Price of All Prescriptions

Rank: 37 out of 393

832 Patients Receiving at Least One Drug in Part D
87%Patients 65 Years and Older
18% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Nevada
Lower avg

Schedule Two
Controlled Substances

6% of this provider’s 832 patients filled at least one prescription for a schedule two drug, compared to an average of 7%.

Schedule Three
Controlled Substances

18% of this provider’s 832 patients filled at least one prescription for a schedule three drug, compared to an average of 14%.

Risky Drugs to Seniors

3% of this provider’s 11,240 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

16% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$47 was the average price of a prescription from this provider, compared to $54 among peers.

Prescriptions per Patient

16 is the average number of prescriptions (including refills) per patient, compared to an average of 15.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Nevada
LISINOPRIL 736 618 1 2
HYDROCODONE-ACETAMINOPHEN 669 503 S3 2 5
LEVOTHYROXINE SODIUM 648 585 3 3
SIMVASTATIN 568 494 4 1
AMLODIPINE BESYLATE 437 393 5 4
OMEPRAZOLE 391 317 6 6
LOVASTATIN 312 293 7 14
METFORMIN HCL 282 240 8 7
METOPROLOL TARTRATE 265 227 9 9
AZITHROMYCIN 258 210 10 35
ATENOLOL 219 189 11 13
GABAPENTIN 219 148 11 15
ZOLPIDEM TARTRATE 213 152 13 11
FUROSEMIDE 209 177 14 8
POTASSIUM CHLORIDE 202 178 15 20
LOSARTAN POTASSIUM 177 154 16 12
WARFARIN SODIUM 174 153 17 17
HYDROCHLOROTHIAZIDE 150 145 18 10
CLONIDINE HCL 132 96 19 50
ATORVASTATIN CALCIUM 131 126 20 19
ALENDRONATE SODIUM 128 120 21 16
GLYBURIDE 118 107 R 22 46
LISINOPRIL-HYDROCHLOROTHIAZIDE 115 90 23 24
PRAVASTATIN SODIUM 110 102 24 18
AMOX TR-POTASSIUM CLAVULANATE 109 86 25 100
METOPROLOL SUCCINATE 109 94 25 22
CARISOPRODOL 108 21 R 27 45
GLIPIZIDE 108 99 27 32
CITALOPRAM HBR 107 89 29 23
NEXIUM 103 95 30 84
CLOPIDOGREL 103 99 30 33
CARVEDILOL 100 92 32 21
TERAZOSIN HCL 99 95 33 38
FLUTICASONE PROPIONATE 96 75 34 27
VERAPAMIL ER 90 78 35 86
ALLOPURINOL 88 81 36 26
OXYCODONE HCL-ACETAMINOPHEN 83 54 S2 37 54
ESTRADIOL 78 78 R 38 93
DIOVAN 77 76 39 69
BENAZEPRIL HCL 76 76 40 40
FINASTERIDE 75 75 41 60
SULFAMETHOXAZOLE-TRIMETHOPRIM 75 71 41 111
ISOSORBIDE MONONITRATE ER 74 57 43 67
SERTRALINE HCL 72 64 44 28
SYNTHROID 71 71 45 44
CIPROFLOXACIN HCL 70 54 46 57
DILTIAZEM ER 70 59 46 107
METHYLPREDNISOLONE 69 49 48 80
TAMSULOSIN HCL 69 67 48 25
PANTOPRAZOLE SODIUM 68 62 50 56
DIGOXIN 67 64 51 66
KLOR-CON 10 66 64 52 113
RANITIDINE HCL 65 51 53 29
PLAVIX 65 64 53 51
CEPHALEXIN 63 57 55 131
TRIAMTERENE-HCTZ 63 60 55 49
DONEPEZIL HCL 61 61 57 34
FLUOXETINE HCL 57 42 58 37
LEVOXYL 56 56 59 120
DILTIAZEM 24HR CD 53 47 60 152
GEMFIBROZIL 52 40 61 62
PROAIR HFA 52 32 61 68
TRAMADOL HCL 51 47 63 30
PAROXETINE HCL 50 33 64 61
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on March 2, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.